APA (7th ed.) Citation

CD, P., TTT, T., BZJ, Y., RC, P., E, S., EYM, Y., . . . MTN, L. (2025). Combination of KRAS ASO and RIG-I agonist in extracellular vesicles transforms the tumor microenvironment towards effective treatment of KRAS-dependent cancers. Theranostics, 15(14), 6818. https://doi.org/10.7150/thno.105519

Chicago Style (17th ed.) Citation

CD, Phung, et al. "Combination of KRAS ASO and RIG-I Agonist in Extracellular Vesicles Transforms the Tumor Microenvironment Towards Effective Treatment of KRAS-dependent Cancers." Theranostics 15, no. 14 (2025): 6818. https://doi.org/10.7150/thno.105519.

MLA (9th ed.) Citation

CD, Phung, et al. "Combination of KRAS ASO and RIG-I Agonist in Extracellular Vesicles Transforms the Tumor Microenvironment Towards Effective Treatment of KRAS-dependent Cancers." Theranostics, vol. 15, no. 14, 2025, p. 6818, https://doi.org/10.7150/thno.105519.